SEC Form 4 · accession 0001645627-17-000137
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Nov 7, 2017
Accepted (ET)
Nov 13, 2017 · 3:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 7, 2017 | P | 3,000 | $0.052 | A | 24,121,189 | D | |
| Common Stock | Nov 7, 2017 | P | 3,000 | $0.0549 | A | 24,124,189 | D | |
| Common Stock | Nov 7, 2017 | P | 3,000 | $0.0533 | A | 24,127,189 | D | |
| Common Stock | Nov 7, 2017 | P | 3,000 | $0.0549 | A | 24,130,189 | D | |
| Common Stock | Nov 7, 2017 | P | 3,000 | $0.0499 | A | 24,133,189 | D | |
| Common Stock | Nov 7, 2017 | P | 565 | $0.051 | A | 24,133,754 | D | |
| Common Stock | Nov 7, 2017 | P | 2,435 | $0.0519 | A | 24,136,189 | D | |
| Common Stock | Nov 8, 2017 | P | 3,000 | $0.0425 | A | 24,139,189 | D | |
| Common Stock | Nov 8, 2017 | P | 3,000 | $0.0459 | A | 24,142,189 | D | |
| Common Stock | Nov 8, 2017 | P | 2,000 | $0.046 | A | 24,144,189 | D | |
| Common Stock | Nov 8, 2017 | P | 2,000 | $0.046 | A | 24,146,189 | D | |
| Common Stock | Nov 8, 2017 | P | 3,000 | $0.0449 | A | 24,149,189 | D | |
| Common Stock | Nov 8, 2017 | P | 2,000 | $0.0457 | A | 24,151,189 | D | |
| Common Stock | Nov 9, 2017 | P | 2,000 | $0.0441 | A | 24,153,189 | D |
Table II — derivative securities
No Table II lines on this filing.